GRB 2019 Colorectal Cancer Collaborators. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:627–47.
Article
Google Scholar
Ali ES, Akter S, Ramproshad S, Mondal B, Riaz TA, Islam MT, Khan IN, Docea AO, Calina D, Sharifi-Rad J, Cho WC. Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview. Cancer Cell Int. 2022;22:246.
Article
Google Scholar
Jain D, Chaudhary P, Varshney N, Bin Razzak KS, Verma D, Zahra TRK, Janmeda P, Sharifi-Rad J, Dastan SD, Mahmud S, et al. Tobacco smoking and liver cancer risk: potential avenues for carcinogenesis. J Oncol. 2021;2021:5905357.
Article
Google Scholar
Iqbal MJ, Javed Z, Herrera-Bravo J, Sadia H, Anum F, Raza S, Tahir A, Shahwani MN, Sharifi-Rad J, Calina D, Cho WC. Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation. Cancer Cell Int. 2022;22:354.
Article
Google Scholar
Ianoși SL, Batani A, Ilie MA, Tampa M, Georgescu SR, Zurac S, Boda D, Ianosi NG, Neagoe D, Calina D, et al. Non-invasive imaging techniques for the in vivo diagnosis of Bowen’s disease: three case reports. Oncol Lett. 2019;17:4094–101.
Google Scholar
Pietrobon V. Cancer metabolism. J Transl Med. 2021;19:87.
Article
Google Scholar
Quispe C, Herrera-Bravo J, Javed Z, Khan K, Raza S, Gulsunoglu-Konuskan Z, Daştan SD, Sytar O, Martorell M, Sharifi-Rad J, Calina D. Therapeutic applications of curcumin in diabetes: a review and perspective. Biomed Res Int. 2022;2022:1375892.
Article
Google Scholar
Asgharian P, Tazekand AP, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M, Hasan M, Kumar M, Beirami SM, Tarhriz V, et al. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int. 2022;22:257.
Article
CAS
Google Scholar
Javed Z, Khan K, Herrera-Bravo J, Naeem S, Iqbal MJ, Raza Q, Sadia H, Raza S, Bhinder M, Calina D, et al. Myricetin: targeting signaling networks in cancer and its implication in chemotherapy. Cancer Cell Int. 2022;22:239.
Article
CAS
Google Scholar
Dhyani P, Quispe C, Sharma E, Bahukhandi A, Sati P, Attri DC, Szopa A, Sharifi-Rad J, Docea AO, Mardare I, et al. Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine. Cancer Cell Int. 2022;22:206.
Article
CAS
Google Scholar
Sharifi-Rad J, Herrera-Bravo J, Kamiloglu S, Petroni K, Mishra AP, Monserrat-Mesquida M, Sureda A, Martorell M, Aidarbekovna DS, Yessimsiitova Z, et al. Recent advances in the therapeutic potential of emodin for human health. Biomed Pharmacother. 2022;154:113555.
Article
CAS
Google Scholar
Liu X, Yao L, Qu J, Liu L, Lu N, Wang J, Zhang J. Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression. J Transl Med. 2021;19:325.
Article
CAS
Google Scholar
Alghasham AA. Cucurbitacins—a promising target for cancer therapy. Int J Health Sci (Qassim). 2013;7:77–89.
Google Scholar
Kaya G, Melzig M. Quantitative determination of cucurbitacin E and cucurbitacin I in homoeopathic mother tincture of Gratiola officinalis L. by HPLC. Die Pharmazie-Int J Pharm Sci. 2008;63:851–3.
CAS
Google Scholar
Olmedo D, Rodríguez N, Vásquez Y, Solis P, Lopez-Perez J, Feliciano AS, Gupta M. A new coumarin from the fruits of Coutarea hexandra. Nat Prod Res. 2007;21:625–31.
Article
CAS
Google Scholar
Salehi B, Sharifi-Rad J, Capanoglu E, Adrar N, Catalkaya G, Shaheen S, Jaffer M, Giri L, Suyal R, Jugran AK, et al. Cucurbita plants: from farm to industry. Appl Sci-Basel. 2019;9:21.
Google Scholar
Rolnik A, Olas B. Vegetables from the Cucurbitaceae family and their products: positive effect on human health. Nutrition. 2020;78:110788.
Article
CAS
Google Scholar
Salehi B, Capanoglu E, Adrar N, Catalkaya G, Shaheen S, Jaffer M, Giri L, Suyal R, Jugran AK, Calina D, et al. Cucurbits plants: a key emphasis to its pharmacological potential. Molecules. 2019;24:23.
Article
Google Scholar
WFO The World Flora Online. http://www.worldfloraonline.org/.
Chemspider. http://www.chemspider.com/.
Painuli S, Quispe C, Herrera-Bravo J, Semwal P, Martorell M, Almarhoon ZM, Seilkhan A, Ydyrys A, Rad JS, Alshehri MM, et al. Nutraceutical profiling, bioactive composition, and biological applications of Lepidium sativum L. Oxid Med Cell Longev. 2022;2022:2910411.
Article
Google Scholar
Hossain R, Quispe C, Saikat ASM, Jain D, Habib A, Janmeda P, Islam MT, Radha S, Daştan SD, Kumar M, et al. Biosynthesis of secondary metabolites based on the regulation of microRNAs. Biomed Res Int. 2022;2022:9349897.
Article
Google Scholar
Clericuzio M, Mella M, Vita-Finzi P, Zema M, Vidari G. Cucurbitane triterpenoids from Leucopaxillus gentianeus. J Nat Prod. 2004;67:1823–8.
Article
CAS
Google Scholar
Islam MT, Quispe C, El-Kersh DM, Shill MC, Bhardwaj K, Bhardwaj P, Sharifi-Rad J, Martorell M, Hossain R, Al-Harrasi A, et al. A literature-based update on Benincasa hispida (Thunb.) Cogn.: traditional uses, nutraceutical, and phytopharmacological profiles. Oxid Med Cell Longev. 2021;2021:6349041.
Article
Google Scholar
Ul Haq F, Ali A, Khan MN, Shah SMZ, Kandel RC, Aziz N, Adhikari A, Choudhary MI, El-Seedi HR, Musharraf SG. Metabolite profiling and quantitation of cucurbitacins in Cucurbitaceae plants by liquid chromatography coupled to tandem mass spectrometry. Sci Rep. 2019;9:1–11.
Article
CAS
Google Scholar
Kaushik U, Aeri V, Mir SR. Cucurbitacins—an insight into medicinal leads from nature. Pharmacogn Rev. 2015;9:12–8.
Article
CAS
Google Scholar
Omokhua-Uyi AG, Van Staden J. Phytomedicinal relevance of South African Cucurbitaceae species and their safety assessment: a review. J Ethnopharmacol. 2020;259:112967.
Article
CAS
Google Scholar
Muruganantham N, Solomon S, Senthamilselvi M. Anti-cancer activity of Cucumis sativus (cucumber) flowers against human liver cancer. Int J Pharm Clin Res. 2016;8:39–41.
Google Scholar
Rajasree R, Sibi P, Francis F, William H. Phytochemicals of Cucurbitaceae family—a review. Int J Pharmacogn Phytochem Res. 2016;8:113–23.
Google Scholar
Hou X, Meehan EJ, Xie J, Huang M, Chen M, Chen L. Atomic resolution structure of cucurmosin, a novel type 1 ribosome-inactivating protein from the sarcocarp of Cucurbita moschata. J Struct Biol. 2008;164:81–7.
Article
CAS
Google Scholar
Manchali S, Chidambara Murthy KN, Vishnuvardana S, Patil BS. Nutritional composition and health benefits of various botanical types of melon (Cucumis melo L.). Plants (Basel). 2021;10:1755.
Article
CAS
Google Scholar
Vella FM, Cautela D, Laratta B. Characterization of polyphenolic compounds in cantaloupe melon by-products. Foods. 2019;8:196.
Article
CAS
Google Scholar
Huerta-Reyes M, Tavera-Hernández R, Alvarado-Sansininea JJ, Jiménez-Estrada M. Selected species of the Cucurbitaceae family used in Mexico for the treatment of diabetes mellitus. Molecules. 2022;27:3440.
Article
CAS
Google Scholar
Bardaa S, Ben Halima N, Aloui F, Ben Mansour R, Jabeur H, Bouaziz M, Sahnoun Z. Oil from pumpkin (Cucurbita pepo L.) seeds: evaluation of its functional properties on wound healing in rats. Lipids Health Dis. 2016;15:1–12.
Article
Google Scholar
Wang D-C, Pan H-Y, Deng X-M, Xiang H, Gao H-Y, Cai H, Wu L-J. Cucurbitane and hexanorcucurbitane glycosides from the fruits of Cucurbita pepo cv dayangua. J Asian Nat Prod Res. 2007;9:525–9.
Article
CAS
Google Scholar
Martínez-Valdivieso D, Font R, Fernández-Bedmar Z, Merinas-Amo T, Gómez P, Alonso-Moraga Á, del Río-Celestino M. Role of zucchini and its distinctive components in the modulation of degenerative processes: genotoxicity, anti-genotoxicity, cytotoxicity and apoptotic effects. Nutrients. 2017;9:755.
Article
Google Scholar
Melim C, Lauro MR, Pires IM, Oliveira PJ, Cabral C. The role of glucosinolates from cruciferous vegetables (Brassicaceae) in gastrointestinal cancers: from prevention to therapeutics. Pharmaceutics. 2022;14:190.
Article
CAS
Google Scholar
Favela-González KM, Hernández-Almanza AY, De la Fuente-Salcido NM. The value of bioactive compounds of cruciferous vegetables (Brassica) as antimicrobials and antioxidants: a review. J Food Biochem. 2020;44:e13414.
Article
Google Scholar
Dong L, Almeida A, Pollier J, Khakimov B, Bassard J-E, Miettinen K, Stærk D, Mehran R, Olsen CE, Motawia MS. An independent evolutionary origin for insect deterrent cucurbitacins in Iberis amara. Mol Biol Evol. 2021;38:4659–73.
Article
CAS
Google Scholar
Khayyal MT, Agha AM, Zaki HF, El-Sahar A, Abdel-Aziz H. Mechanisms involved in the anti-inflammatory and vascular effects of Iberis amara extract. Planta Med. 2015;81:1097–102.
Article
CAS
Google Scholar
Zou J-M, Wang L-S, Ma X-M, Guo Y-J, Shi R-B. A new cucurbitacin from Picria fel-terrae: Note. J Asian Nat Prod Res. 2006;8:367–71.
Article
CAS
Google Scholar
Kim IH, Uchiyama N, Kawahara N, Goda Y. Iridoid glycosides and cucurbitacin glycoside from Neopicrorhiza scrophulariiflora. Phytochemistry. 2006;67:2691–6.
Article
CAS
Google Scholar
Wu P-L, Lin F-W, Wu T-S, Kuoh C-S, Lee K-H, Lee S-J. Cytotoxic and anti-HIV principles from the rhizomes of Begonia nantoensis. Chem Pharm Bull. 2004;52:345–9.
Article
CAS
Google Scholar
Muñoz O, Delporte C, Backhouse N, Erazo S, Negrete R, Maldonado S, López-Pérez JL, San Feliciano A. A new cucurbitacin glycoside from Kageneckia oblonga (Rosaceae). Zeitschrift für Naturforschung C. 2000;55:141–5.
Article
Google Scholar
Delporte C, Munozb O, Rojas J, Ferrándiz M, Payá M, Erazo S, Negrete R, Maldonado S, San Feliciano A, Backhouse N. Pharmaco-toxicological study of Kageneckia oblonga, Rosaceae. Zeitschrift für Naturforschung C. 2002;57:100–8.
Article
CAS
Google Scholar
Wan J, Wang X-J, Guo N, Wu X-Y, Xiong J, Zang Y, Jiang C-X, Han B, Li J, Hu J-F. Highly oxygenated triterpenoids and diterpenoids from Fructus Rubi (Rubus chingii Hu) and their NF-kappa B inhibitory effects. Molecules. 1911;2021:26.
Google Scholar
Chen C-H, Kuo TC-Y, Yang M-H, Chien T-Y, Chu M-J, Huang L-C, Chen C-Y, Lo H-F, Jeng S-T, Chen L-FO. Identification of cucurbitacins and assembly of a draft genome for Aquilaria agallocha. BMC Genomics. 2014;15:1–11.
Article
Google Scholar
Fujimoto H, Hagiwara H, Suzuki K, Yamazaki M. New toxic metabolites from a mushroom, Hebeloma vinosophyllum. II. isolation and structures of hebevinosides VI, VII, VIII, IX, X, and XI. Chem Pharm Bull. 1987;35:2254–60.
Article
CAS
Google Scholar
Fujimoto H, Suzuki K, Hagiwara H, Yamazaki M. New Toxic Metabolites from a Mushroom, Hebeloma vinosophyllum. I.: Structures of hebevinosides I, II, III, IV, and V. Chem Pharm Bull. 1986;34:88–99.
Article
CAS
Google Scholar
Jian-Wen T, Ze-Jun D, Ji-Kai L. New terpenoids from basidiomycetes Russula lepida. Helv Chim Acta. 2000;83:3191–7.
Article
Google Scholar
Lee J-S, Maarisit W, Abdjul DB, Yamazaki H, Takahashi O, Kirikoshi R, Kanno S-I, Namikoshi M. Structures and biological activities of triterpenes and sesquiterpenes obtained from Russula lepida. Phytochemistry. 2016;127:63–8.
Article
CAS
Google Scholar
Maarisit W, Yamazaki H, Kanno S-I, Tomizawa A, Lee J-S, Namikoshi M. Protein tyrosine phosphatase 1B inhibitory properties of seco-cucurbitane triterpenes obtained from fruiting bodies of Russula lepida. J Nat Med. 2017;71:334–7.
Article
CAS
Google Scholar
Clericuzio M, Tabasso S, Bianco MA, Pratesi G, Beretta G, Tinelli S, Zunino F, Vidari G. Cucurbitane triterpenes from the fruiting bodies and cultivated mycelia of Leucopaxillus gentianeus. J Nat Prod. 2006;69:1796–9.
Article
CAS
Google Scholar
Graziani EI, Allen TM, Andersen RJ. Lovenone, a cytotoxic degraded triterpenoid isolated from skin extracts of the North Sea dorid nudibranch Adalaria loveni. Tetrahedron Lett. 1995;36:1763–6.
Article
CAS
Google Scholar
Dhyani P, Sati P, Sharma E, Attri DC, Bahukhandi A, Tynybekov B, Szopa A, Sharifi-Rad J, Calina D, Suleria HAR, Cho WC. Sesquiterpenoid lactones as potential anti-cancer agents: an update on molecular mechanisms and recent studies. Cancer Cell Int. 2022;22:305.
Article
CAS
Google Scholar
Ali ES, Mitra K, Akter S, Ramproshad S, Mondal B, Khan IN, Islam MT, Sharifi-Rad J, Calina D, Cho WC. Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Cancer Cell Int. 2022;22:284.
Article
CAS
Google Scholar
Irfan M, Javed Z, Khan K, Khan N, Docea AO, Calina D, Sharifi-Rad J, Cho WC. Apoptosis evasion via long non-coding RNAs in colorectal cancer. Cancer Cell Int. 2022;22:280.
Article
CAS
Google Scholar
Sharifi-Rad J, Herrera-Bravo J, Semwal P, Painuli S, Badoni H, Ezzat SM, Farid MM, Merghany RM, Aborehab NM, Salem MA, et al. Artemisia spp.: an update on its chemical composition, pharmacological and toxicological profiles. Oxid Med Cell Longev. 2022;2022:5628601.
Article
Google Scholar
Aiswarya SUD, Vikas G, Haritha NH, Liju VB, Shabna A, Swetha M, Rayginia TP, Keerthana CK, Nath LR, Reshma MV, et al. Cucurbitacin B, purified and characterized from the rhizome of corallocarpus epigaeus exhibits anti-melanoma potential. Front Oncol. 2022;12:903832.
Article
Google Scholar
Liu X, Duan C, Ji J, Zhang T, Yuan X, Zhang Y, Ma W, Yang J, Yang L, Jiang Z, et al. Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells. Oncol Rep. 2017;38:271–8.
Article
Google Scholar
Zhou X, Yang J, Wang Y, Li W, Li-Ling J, Deng Y, Zhang M. Cucurbitacin B inhibits 12-O-tetradecanoylphorbol 13-acetate-induced invasion and migration of human hepatoma cells through inactivating mitogen-activated protein kinase and PI3K/Akt signal transduction pathways. Hepatol Res. 2012;42:401–11.
Article
CAS
Google Scholar
Shukla S, Khan S, Kumar S, Sinha S, Farhan M, Bora HK, Maurya R, Meeran SM. Cucurbitacin B alters the expression of tumor-related genes by epigenetic modifications in NSCLC and inhibits NNK-induced lung tumorigenesis. Cancer Prev Res (Phila). 2015;8:552–62.
Article
CAS
Google Scholar
Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K, Maurya R, Meeran SM. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/beta-catenin signaling axis. Sci Rep. 2016;6:21860.
Article
CAS
Google Scholar
Klungsaeng S, Kukongviriyapan V, Prawan A, Kongpetch S, Senggunprai L. Targeted modulation of FAK/PI3K/PDK1/AKT and FAK/p53 pathways by cucurbitacin B for the antiproliferation effect against human cholangiocarcinoma cells. Am J Chin Med. 2020;48:1475–89.
Article
CAS
Google Scholar
Gupta P, Srivastava SK. Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression. Oncotarget. 2014;5:1812–28.
Article
Google Scholar
Duangmano S, Sae-Lim P, Suksamrarn A, Domann FE, Patmasiriwat P. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation. BMC Complement Altern Med. 2012;12:185.
Article
CAS
Google Scholar
Liang J, Zhang XL, Yuan JW, Zhang HR, Liu D, Hao J, Ji W, Wu XZ, Chen D. Cucurbitacin B inhibits the migration and invasion of breast cancer cells by altering the biomechanical properties of cells. Phytother Res. 2019;33:618–30.
CAS
Google Scholar
Gao Y, Islam MS, Tian J, Lui VW, Xiao D. Inactivation of ATP citrate lyase by cucurbitacin B: a bioactive compound from cucumber, inhibits prostate cancer growth. Cancer Lett. 2014;349:15–25.
Article
CAS
Google Scholar
Touihri-Barakati I, Kallech-Ziri O, Ayadi W, Kovacic H, Hanchi B, Hosni K, Luis J. Cucurbitacin B purified from Ecballium elaterium (L.) A. Rich from Tunisia inhibits alpha5beta1 integrin-mediated adhesion, migration, proliferation of human glioblastoma cell line and angiogenesis. Eur J Pharmacol. 2017;797:153–61.
Article
CAS
Google Scholar
Sikander M, Hafeez BB, Malik S, Alsayari A, Halaweish FT, Yallapu MM, Chauhan SC, Jaggi M. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer. Sci Rep. 2016;6:36594.
Article
CAS
Google Scholar
Kim MS, Lee K, Ku JM, Choi YJ, Mok K, Kim D, Cheon C, Ko SG. Cucurbitacin D induces G2/M phase arrest and apoptosis via the ROS/p38 pathway in Capan-1 pancreatic cancer cell line. Evid Based Complement Alternat Med. 2020;2020:6571674.
Article
Google Scholar
Jacquot C, Rousseau B, Carbonnelle D, Chinou I, Malleter M, Tomasoni C, Roussakis C. Cucurbitacin-D-induced CDK1 mRNA up-regulation causes proliferation arrest of a non-small cell lung carcinoma cell line (NSCLC-N6). Anticancer Res. 2014;34:4797–806.
CAS
Google Scholar
Cheng AC, Hsu YC, Tsai CC. The effects of cucurbitacin E on GADD45β-trigger G2/M arrest and JNK-independent pathway in brain cancer cells. J Cell Mol Med. 2019;23:3512–9.
Article
CAS
Google Scholar
Jing SY, Wu ZD, Zhang TH, Zhang J, Wei ZY. In vitro antitumor effect of cucurbitacin E on human lung cancer cell line and its molecular mechanism. Chin J Nat Med. 2020;18:483–90.
CAS
Google Scholar
Hsu YC, Chen MJ, Huang TY. Inducement of mitosis delay by cucurbitacin E, a novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45gamma in human brain malignant glioma (GBM) 8401 cells. Cell Death Dis. 2014;5:e1087.
Article
CAS
Google Scholar
Li H, Chen H, Li R, Xin J, Wu S, Lan J, Xue K, Li X, Zuo C, Jiang W, Zhu L. Cucurbitacin I induces cancer cell death through the endoplasmic reticulum stress pathway. J Cell Biochem. 2018;120:2391–403.
Article
Google Scholar
Kim HJ, Park JH, Kim JK. Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer. Chem Biol Interact. 2014;219:1–8.
Article
CAS
Google Scholar
Zhang J, Song Y, Liang Y, Zou H, Zuo P, Yan M, Jing S, Li T, Wang Y, Li D, et al. Cucurbitacin IIa interferes with EGFR-MAPK signaling pathway leads to proliferation inhibition in A549cells. Food Chem Toxicol. 2019;132: 110654.
Article
CAS
Google Scholar
Liang Y, Zhang T, Ren L, Jing S, Li Z, Zuo P, Li T, Wang Y, Zhang J, Wei Z. Cucurbitacin IIb induces apoptosis and cell cycle arrest through regulating EGFR/MAPK pathway. Environ Toxicol Pharmacol. 2021;81:103542.
Article
CAS
Google Scholar
Torres-Moreno H, Marcotullio MC, Velazquez C, Ianni F, Garibay-Escobar A, Robles-Zepeda RE. Cucurbitacin IIb, a steroidal triterpene from Ibervillea sonorae induces antiproliferative and apoptotic effects on cervical and lung cancer cells. Steroids. 2020;157: 108597.
Article
CAS
Google Scholar
Sharifi-Rad J, Quispe C, Patra JK, Singh YD, Panda MK, Das G, Adetunji CO, Michael OS, Sytar O, Polito L, et al. Paclitaxel: application in modern oncology and nanomedicine-based cancer therapy. Oxid Med Cell Longev. 2021;2021:3687700.
Article
Google Scholar
Sharifi-Rad J, Quispe C, Butnariu M, Rotariu LS, Sytar O, Sestito S, Rapposelli S, Akram M, Iqbal M, Krishna A, et al. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer Cell Int. 2021;21:318–318.
Article
CAS
Google Scholar
Salehi B, Prakash Mishra A, Nigam M, Karazhan N, Shukla I, Kiełtyka-Dadasiewicz A, Sawicka B, Głowacka A, Abu-Darwish MS, Hussein Tarawneh A, et al. Ficus plants: state of the art from a phytochemical, pharmacological, and toxicological perspective. Phytother Res. 2021;35:1187–217.
Article
CAS
Google Scholar
Sharifi-Rad J, Kamiloglu S, Yeskaliyeva B, Beyatli A, Alfred MA, Salehi B, Calina D, Docea AO, Imran M, Kumar NVA, et al. Pharmacological activities of psoralidin: a comprehensive review of the molecular mechanisms of action. Front Pharmacol. 2020;11:11.
Article
Google Scholar
Sharifi-Rad J, Quispe C, Imran M, Rauf A, Nadeem M, Gondal TA, Ahmad B, Atif M, Mubarak MS, Sytar O, et al. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxid Med Cell Longev. 2021;2021:3268136.
Article
Google Scholar
Bakar F. Cucurbitacin B enhances the anticancer effect of imatinib mesylate through inhibition of MMP-2 expression in MCF-7 and SW480 tumor cell lines. Anti-Cancer Agents Med Chem. 2016;16:747–54.
Article
CAS
Google Scholar
Aribi A, Gery S, Lee DH, Thoennissen NH, Thoennissen GB, Alvarez R, Ho Q, Lee K, Doan NB, Chan KT. The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer. Int J Cancer. 2013;132:2730–7.
Article
CAS
Google Scholar
Zhang M, Yin L, Yang S, Hong J, Chen C, Han D, Hou Y, Zhang B, Huang L, Zhang A. The synergistic effect of Cucurbitacin B and radiation treatment. Cancer Res. 2012;72:5728–5728.
Article
Google Scholar
Zhou J, Zhao T, Ma L, Liang M, Guo Y-J, Zhao L-M. Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling. Oncotarget. 2017;8: 103167.
Article
Google Scholar
Yar Saglam A, Alp E, Elmazoglu Z, Menevse S. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines. Hum Exp Toxicol. 2016;35:526–43.
Article
CAS
Google Scholar
El-Senduny FF, Badria FA, El-Waseef AM, Chauhan SC, Halaweish F. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B. Tumor Biol. 2016;37:685–98.
Article
CAS
Google Scholar
Qu Y, Cong P, Lin C, Deng Y, Li-Ling J, Zhang M. Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells. Oncol Lett. 2017;14:145–52.
Article
CAS
Google Scholar
Lee DH, Thoennissen NH, Goff C, Iwanski GB, Forscher C, Doan NB, Said JW, Koeffler HP. Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. Cancer Lett. 2011;306:161–70.
Article
CAS
Google Scholar
Hossain R, Ray P, Sarkar C, Islam MS, Khan RA, Khalipha ABR, Islam MT, Cho WC, Martorell M, Sharifi-Rad J, et al. Natural compounds or their derivatives against breast cancer: a computational study. Biomed Res Int. 2022;2022:5886269.
Article
Google Scholar
Amir S, Shah STA, Mamoulakis C, Docea AO, Kalantzi O-I, Zachariou A, Calina D, Carvalho F, Sofikitis N, Makrigiannakis A, Tsatsakis A. Endocrine disruptors acting on estrogen and androgen pathways cause reproductive disorders through multiple mechanisms: a review. Int J Environ Res Public Health. 2021;18:1464.
Article
CAS
Google Scholar
Chainitikun S, Saleem S, Lim B, Valero V, Ueno NT. Update on systemic treatment for newly diagnosed inflammatory breast cancer. J Adv Res. 2021;29:1–12.
Article
CAS
Google Scholar
Luo S, Wang H, Bai L, Chen Y, Chen S, Gao K, Wang H, Wu S, Song H, Ma K, et al. Activation of TMEM16A Ca2+-activated Cl− channels by ROCK1/moesin promotes breast cancer metastasis. J Adv Res. 2021;33:253–64.
Article
CAS
Google Scholar
Quetglas-Llabrés MM, Quispe C, Herrera-Bravo J, Catarino MD, Pereira OR, Cardoso SM, Dua K, Chellappan DK, Pabreja K, Satija S, et al. Pharmacological properties of bergapten: mechanistic and therapeutic aspects. Oxid Med Cell Longev. 2022;2022:8615242.
Article
Google Scholar
Mitrut P, Docea AO, Kamal AM, Mitrut R, Calina D, Gofita E, Padureanu V, Gruia C, Streba L. Colorectal cancer and inflammatory bowel disease. 2016.
Sharifi-Rad J, Rodrigues CF, Stojanovic-Radic Z, Dimitrijevic M, Aleksic A, Neffe-Skocinska K, Zielinska D, Kolozyn-Krajewska D, Salehi B, Prabu SM, et al. Probiotics: versatile bioactive components in promoting human health. Medicina-Lithuania. 2020;56:30.
Google Scholar
Zlatian OM, Comanescu MV, Rosu AF, Rosu L, Cruce M, Gaman AE, Calina CD, Sfredel V. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer. Rom J Morphol Embryol. 2015;56:175–81.
Google Scholar
Tanase A, Colita A, Ianosi G, Neagoe D, Branisteanu DE, Calina D, Docea AO, Tsatsakis A, Ianosi SL. Rare case of disseminated fusariosis in a young patient with graft vs host disease following an allogeneic transplant. Exp Ther Med. 2016;12:2078–82.
Article
CAS
Google Scholar
Calina D, Rosu L, Rosu AF, Ianosi G, Ianosi S, Zlatian O, Mitrut R, Docea AO, Rogoveanu O, Mitrut P, et al. Etiological diagnosis and pharmacotherapeutic management of parapneumonic pleurisy. Farmacia. 2016;64:946–52.
CAS
Google Scholar
Ungureanu A, Zlatian O, Mitroi G, Drocas A, Tirca T, Calina D, Dehelean C, Docea AO, Izotov BN, Rakitskii VN, et al. Staphylococcus aureus colonisation in patients from a primary regional hospital. Mol Med Rep. 2017;16:8771–80.
Article
CAS
Google Scholar
Zlatian O, Balasoiu AT, Balasoiu M, Cristea O, Docea AO, Mitrut R, Spandidos DA, Tsatsakis AM, Bancescu G, Calina D. Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections. Exp Ther Med. 2018;16:4499–510.
CAS
Google Scholar
Kitic D, Miladinovic B, Randjelovic M, Szopa A, Sharifi-Rad J, Calina D, Seidel V. Anticancer potential and other pharmacological properties of Prunus armeniaca L.: an updated overview. Plants. 2022;11:1885.
Article
CAS
Google Scholar
Sharifi-Rad J, Dey A, Koirala N, Shaheen S, El Omari N, Salehi B, Goloshvili T, Cirone Silva NC, Bouyahya A, Vitalini S, et al. Cinnamomum species: bridging phytochemistry knowledge, pharmacological properties and toxicological safety for health benefits. Front Pharmacol. 2021;12:600139–600139.
Article
CAS
Google Scholar
Boda D, Docea AO, Calina D, Ilie MA, Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE, Voiculescu V, et al. Human papilloma virus: apprehending the link with carcinogenesis and unveiling new research avenues (Review). Int J Oncol. 2018;52:637–55.
CAS
Google Scholar
Sharifi-Rad J, Quispe C, Rahavian A, Pereira Carneiro JN, Rocha JE, Alves Borges Leal AL, Bezerra Morais Braga MF, Melo Coutinho HD, Ansari Djafari A, Alarcón-Zapata P, et al. Bioactive compounds as potential agents for sexually transmitted diseases management: a review to explore molecular mechanisms of action. Front Pharmacol. 2021;12:1886.
Article
Google Scholar
Cole S, Gianferante DM, Zhu B, Mirabello L. Osteosarcoma: a surveillance, epidemiology, and end results program-based analysis from 1975 to 2017. Cancer. 2022;128:2107–18.
Article
Google Scholar
Sani TA, Mohammadpour E, Mohammadi A, Memariani T, Yazdi MV, Rezaee R, Calina D, Docea AO, Goumenou M, Etemad L, Shahsavand S. Cytotoxic and apoptogenic properties of Dracocephalum Kotschyi aerial part different fractions on calu-6 and mehr-80 lung cancer cell lines. Farmacia. 2017;65:189–99.
CAS
Google Scholar
Buga AM, Docea AO, Albu C, Malin RD, Branisteanu DE, Ianosi G, Ianosi SL, Iordache A, Calina D. Molecular and cellular stratagem of brain metastases associated with melanoma. Oncol Lett. 2019;17:4170–5.
CAS
Google Scholar
Sharifi-Rad J, Quispe C, Durazzo A, Lucarini M, Souto EB, Santini A, Imran M, Moussa AY, Mostafa NM, El-Shazly M, et al. Resveratrol’ biotechnological applications: enlightening its antimicrobial and antioxidant properties. J Herb Med. 2022;32:100550.
Article
Google Scholar
Hu C, Iwasaki M, Liu Z, Wang B, Li X, Lin H, Li J, Li JV, Lian Q, Ma D. Lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: implication of reducing cancer recurrence risk. J Adv Res. 2021;31:1–12.
Article
CAS
Google Scholar
Bauer C, Herwig R, Lienhard M, Prasse P, Scheffer T, Schuchhardt J. Large-scale literature mining to assess the relation between anti-cancer drugs and cancer types. J Transl Med. 2021;19:274.
Article
Google Scholar
Kirdeeva Y, Fedorova O, Daks A, Barlev N, Shuvalov O. How should the worldwide knowledge of traditional cancer healing be integrated with herbs and mushrooms into modern molecular pharmacology? Pharmaceuticals (Basel). 2022;15:868.
Article
CAS
Google Scholar
Quispe C, Herrera-Bravo J, Khan K, Javed Z, Semwal P, Painuli S, Kamiloglu S, Martorell M, Calina D, Sharifi-Rad J. Therapeutic applications of curcumin nanomedicine formulations in cystic fibrosis. Progr Biomater. 2022;11:321–9.
Article
CAS
Google Scholar
Salehi B, Calina D, Docea AO, Koirala N, Aryal S, Lombardo D, Pasqua L, Taheri Y, Castillo CMS, Martorell M, et al. Curcumin’s Nanomedicine formulations for therapeutic application in neurological diseases. J Clin Med. 2020;9:35.
Google Scholar
Musat G, Evsei A, Calina D, Docea AO, Doukas SG, Vageli DP, Nepka C, Spandidos DA, Mitroi M. Rare amyloidoma of the tongue base: a case report and review of the literature. Mol Clin Oncol. 2020;12:258–62.
Google Scholar